These results highlight the implication of BTN3A1 for inflammation and SLE development, and suggest a novel mechanism by which BTN3A1 is involved in ferroptosis of CD4+ T cells through inhibition of IL‐38. This evidence concerns the gene CD4 and systemic lupus erythematosus.